par Abdel Azim, Hatem Hamdy 
;Awada, Ahmad
Référence Current opinion in oncology, 24, 3, page (325-331)
Publication Publié, 2012-05
;Awada, Ahmad Référence Current opinion in oncology, 24, 3, page (325-331)
Publication Publié, 2012-05
Article révisé par les pairs
| Titre: |
|
| Auteur: | Abdel Azim, Hatem Hamdy; Awada, Ahmad |
| Informations sur la publication: | Current opinion in oncology, 24, 3, page (325-331) |
| Statut de publication: | Publié, 2012-05 |
| Sujet CREF: | Cancérologie |
| Mots-clés: | amrubicin |
| chemotherapy | |
| EndoTAG-1 | |
| new formulations | |
| NKTR-102 | |
| pralatrexate | |
| MeSH keywords: | Aminopterin -- analogs & derivatives -- pharmacology |
| Anthracyclines -- pharmacology | |
| Antineoplastic Agents -- pharmacology | |
| Camptothecin -- analogs & derivatives -- pharmacology | |
| Chemistry, Pharmaceutical | |
| Folic Acid Antagonists -- pharmacology | |
| Humans | |
| Neoplasms -- drug therapy -- pathology | |
| Paclitaxel -- pharmacology | |
| Topoisomerase I Inhibitors -- pharmacology | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| SCOPUS: re.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1040-8746 |
| info:doi/10.1097/CCO.0b013e328351fb29 | |
| info:scp/84859873049 | |
| info:pmid/22343388 |
